Percutaneous coronary intervention following intravenous fibrinolytic therapy: should it be a must?

Should Aortic Valve Calcification be Checked Before Percutaneous Coronary Intervention?

Percutaneous coronary intervention in women: should management be different?

2014 Women undergoing percutaneous coronary intervention (PCI) have poorer unadjusted outcomes as they are older and have greater comorbidity compared with men, but uncertainty remains whether gender affects outcome after these differences in clinical characteristics are taken into account. In this paper, we review recent published evidence comparing outcomes between men and women undergoing PC...

Should routine platelet testing be done on all patients undergoing percutaneous coronary intervention? Routine Platelet Testing Should Not Be Performed on All Patients Undergoing Percutaneous Coronary Intervention

We all know that clopidogrel reduces thrombotic complications during and after a percutaneous coronary intervention (PCI) procedure. Because clopidogrel is a prodrug and only 2% of ingested clopidogrel is ultimately bound to platelets, it is entirely possible, even likely, that small differences in metabolism that lead to a reduction in the formation of the active metabolite could potentially h...

Prolonged jaundice following percutaneous coronary intervention and ticlopidine therapy.

Ticlopidine, an adenosine diphosphate receptor blocker, is widely used to prevent subacute stent thrombosis after percutaneous coronary intervention. Along with neutropenia and thrombotic thrombocytopenic purpura, cholestatic hepatitis is one of the most serious potential side-effects of ticlopidine therapy. Four patients with prolonged jaundice after ticlopidine therapy, including one fatal ca...

Transradial Versus Transfemoral Access in Patients Undergoing Rescue Percutaneous Coronary Intervention After Fibrinolytic Therapy.

OBJECTIVES The purpose of this study was to assess usage patterns of transradial access in rescue percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) and associations between vascular access site choice and outcomes. BACKGROUND Transradial access reduces bleeding and mortality in STEMI patients undergoing primary PCI. Little is known about access si...